A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
Antiviral Therapy
Saved in:
Main Authors: | Lim, S.G., Wai, C.-T., Lee, Y.M., Dan, Y.Y., Sutedja, D.S., Wee, A., Suresh, S., Wu, Y.J., Machin, D., Lim, C.C., Fock, K.M., Koay, E., Bowden, S., Locarnini, S., Ishaque, S.M. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2012
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/33127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011) -
The regression of recurrent conjunctival papillomas by lymphoblastoid interferon treatment
by: Y. Chiemchaisri, et al.
Published: (2018) -
Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy
by: Cheng, Y., et al.
Published: (2016) -
Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia
by: Lee, L.Y., et al.
Published: (2022) -
Characteristics, prevalence, and HBeAg correlation of hepatitis B in pregnancy: A Siriraj Hospital experience
by: M. Thamkhantho, et al.
Published: (2020)